Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Alcon Inc.    ALC   CH0432492467

ALCON INC.

(ALC)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
02/17/2020 02/18/2020 02/19/2020 02/20/2020 02/21/2020 Date
61.82(c) 61.9(c) 62.38(c) 62.17(c) 62.01 Last
615 349 728 404 818 030 844 006 2 198 102 Volume
+0.57% +0.13% +0.78% -0.34% -0.26% Change
More quotes
Financials (USD)
Sales 2019 7 412 M
EBIT 2019 1 259 M
Net income 2019 -597 M
Debt 2019 2 720 M
Yield 2019 0,14%
Sales 2020 7 770 M
EBIT 2020 1 387 M
Net income 2020 -0,40 M
Debt 2020 2 177 M
Yield 2020 0,26%
P/E ratio 2019 -52,7x
P/E ratio 2020 1 736x
EV / Sales2019 4,55x
EV / Sales2020 4,27x
Capitalization 30 987 M
More Financials
Company
More about the company
Latest news on ALCON INC.
02/20ALCON INC. : annual earnings release
02/17ALCON : to Launch Pataday, the Eye Allergy Drop with the #1 Doctor-Prescribed Ac..
BU
02/03XEROX : PARC, a Xerox Company, Signs Agreement with Alcon on New Eye Care Produc..
AQ
01/29NOVARTIS : Says Taxes Hit 4Q Profit But Expects Growth in 2020
DJ
01/29NOVARTIS AG CHF0.50(REGD) Novartis Delivered -5-
DJ
01/29NOVARTIS AG CHF0.50(REGD) Novartis Delivered -4-
DJ
01/29NOVARTIS AG CHF0.50(REGD) Novartis Delivered -2-
DJ
01/29NOVARTIS AG CHF0.50(REGD) Novartis Delivered Strong Sales Growth, Margin Expa..
DJ
2019ALCON : Second Annual Alcon Retina Fellows Institute Provides World-Class Ophtha..
PU
2019ALCON : SEC Filing 6K-3
CO
2019ALCON : Swiss eyecare company Alcon posts another loss, announces revamp
RE
2019ALCON : 3rd quarter results
CO
2019ALCON : Posts 3Q Loss and Will Restructure Operations
DJ
2019ALCON : Reports Third Quarter and Nine Months 2019 Results
BU
2019US companies stuck with lawsuits and investigations
More news
News in other languages on ALCON INC.
05:31aAktien Schweiz: Coronavirus schürt Sorgen und setzt SMI weiter zu
05:31aBourse Zurich: le SMI toujours en baisse face au coronavirus
02:43aMorning Briefing - Markt Schweiz
12:31aZURICH STOCK EXCHANGE : 4-Wochenvorschau Schweiz
12:21aÉvénements importants des semaines 08 et 09 du 21.02.2020 au 29.02.2020
More news
Analyst Recommendations on ALCON INC.
More recommendations
Sector news : Glasses, Spectacles & Contact lenses
11:41aPharmaceutical companies develop system to better track counterfeit drugs
RE
02/20FISHER & PAYKEL HEALTHCARE : F&P Healthcare Raises Fiscal Year Earnings, Revenue..
DJ
02/20SMITH & NEPHEW : +Nephew forecasts sales growth after best year since 2010
RE
02/18MEDTRONIC : Raises 2020 Guidance, Sets 4Q Outlook
DJ
02/18MEDTRONIC : 3Q Profit, Sales Rise
DJ
More sector news : Glasses, Spectacles & Contact lenses
Chart ALCON INC.
Duration : Period :
Alcon Inc. Technical Analysis Chart | ALC | CH0432492467 | MarketScreener
Technical analysis trends ALCON INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Average target price 58,70  $
Last Close Price 63,18  $
Spread / Highest target 4,46%
Spread / Average Target -7,09%
Spread / Lowest Target -15,5%
EPS Revisions
Managers
NameTitle
David J. Endicott Chief Executive Officer & Director
F. Michael Ball Chairman-Designate
Timothy C. Stonesifer Chief Financial Officer & Senior Vice President
Sue-Jean Lin Chief Information Officer & Senior Vice President
Lynn Dorsey Bleil Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ALCON INC.13.45%31 077
ABBOTT LABORATORIES2.88%156 438
MEDTRONIC PLC0.28%152 662
STRYKER CORPORATION6.92%84 081
BECTON, DICKINSON AND COMPANY-6.81%68 732
BAXTER INTERNATIONAL INC.11.29%47 512